Transforming growth factor-β and smads

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 75-82

  Lan, Hui Yao ^a   Chung, Arthur C K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; DIABETIC NEPHROPATHY; DRUG ANTAGONISM; HUMAN; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DIABETIC NEPHROPATHIES; HUMANS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84925939424     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324949     Document Type: Article

References (30)

1. Kanwar YS, Wada J, Sun L, Xie P, Wallner EI, Chen S, Chugh S, Danesh FR: Diabetic nephropathy: Mechanisms of renal disease progression. Exp Biol Med (Maywood) 2008;233:4-11.
2. Soldatos G, Cooper ME: Diabetic nephropathy: Important pathophysiologic mechanisms. Diabetes Res Clin Pract 2008;82 (suppl 1):S75-S79.
3. Ziyadeh FN: Mediators of diabetic renal disease: The case for TGF-beta as the major mediator. J Am Soc Nephrol 2004;15(suppl 1): S55-S57. (Pubitemid 38018457)
4. Li JH, Huang XR, Zhu HJ, Oldfield M, Cooper M, Truong LD, Johnson RJ, Lan HY: Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: Implications for diabetic renal and vascular disease. FASEB J 2004;18:176-178.
5. Schnaper HW, Hayashida T, Hubchak SC, Poncelet AC: TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol Renal Physiol 2003;284:F243-F252. (Pubitemid 36114687)
6. Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 1998;24: 111-119.
7. Lan HY: Smad7 as a therapeutic agent for chronic kidney diseases. Front Biosci 2008; 13:4984-4992.
8. Chen H, Huang XR, Wang W, Li J, Heuchel RL, Chung AC, Lan HY: The protective role of Smad7 in diabetic kidney disease: Mechanism and therapeutic potential. Diabetes 2011;60:590-601.
9. Meng XM, Huang XR, Chung AC, Qin W, Shao X, Igarashi P, Ju W, Bottinger EP, Lan HY: Smad2 protects against TGF-beta/ Smad3-mediated renal fibrosis. J Am Soc Nephrol 2010;21:1477-1487.
10. Yang F, Chung AC, Huang XR, Lan HY: Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: The role of Smad3. Hypertension 2009;54:877-884.
11. Chung AC, Zhang H, Kong YZ, Tan JJ, Huang XR, Kopp JB, Lan HY: Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling. J Am Soc Nephrol 2010;21:249-260.
12. Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S: Mice lacking Smad3 are protected against streptozotocininduced diabetic glomerulopathy. Biochem Biophys Res Commun 2003;305:1002-1007. (Pubitemid 36597863)
13. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN: Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 2002;296:1356-1365.
14. Derynck R, Zhang YE: Smad-dependent and Smad-independent pathways in TGFbeta family signalling. Nature 2003;425: 577-584. (Pubitemid 37280136)
15. Sengupta U, Ukil S, Dimitrova N, Agrawal S: Expression-based network biology identifies alteration in key regulatory pathways of type 2 diabetes and associated risk/complications. PLoS One 2009;4:e8100.
16. Zhou G, Li C, Cai L: Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol 2004;165:2033-2043. (Pubitemid 39578381)
17. Inoue Y, Imamura T: Regulation of TGFbeta family signaling by E3 ubiquitin ligases. Cancer Sci 2008;99:2107-2112.
18. Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, Wang XJ, Lan HY: Signaling mechanism of TGF-beta1 in prevention of renal inflammation: Role of Smad7. J Am Soc Nephrol 2005;16:1371-1383. (Pubitemid 41716521)
19. Tian Z, Greene AS, Pietrusz JL, Matus IR, Liang M: MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res 2008;18:404-411. (Pubitemid 351347083)
20. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007;104:3432-3437. (Pubitemid 46364176)
21. Chung AC, Huang XR, Meng X, Lan HY: MiR-192 mediates TGF-beta/Smad3- driven renal fibrosis. J Am Soc Nephrol 2010;21: 1317-1325.
22. Wang Q, Wang Y, Minto AW, Wang J, Shi Q, Li X, Quigg RJ: MicroRNA-377 is upregulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008;22:4126-4135.
23. Du B, Ma LM, Huang MB, Zhou H, Huang HL, Shao P, Chen YQ, Qu LH: High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 2010; 584:811-816.
24. Wang B, Koh P, Winbanks C, Coughlan MT, McClelland A, Watson A, Jandeleit-Dahm K, Burns WC, Thomas MC, Cooper ME, Kantharidis P: MiR-200a prevents renal fibrogenesis through repression of TGFbeta2 expression. Diabetes 2011;60:280-287.
25. Balakumar P, Arora MK, Ganti SS, Reddy J, Singh M: Recent advances in pharmacotherapy for diabetic nephropathy: Current perspectives and future directions. Pharmacol Res 2009;60:24-32.
26. Hill C, Flyvbjerg A, Rasch R, Bak M, Logan A: Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 2001;170:647-651. (Pubitemid 32834331)
27. Russo LM, del Re E, Brown D, Lin HY: Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: Amelioration by soluble TGF-beta type II receptor. Diabetes 2007;56:380-388.
28. Petersen M, Thorikay M, Deckers M, van Dinther M, Grygielko ET, Gellibert F, de Gouville AC, Huet S, ten Dijke P, Laping NJ: Oral administration of GW788388, an inhibitor of TGF-beta type I and II receptor kinases, decreases renal fibrosis. Kidney Int 2008;73:705-715. (Pubitemid 351323246)
29. Moon JA, Kim HT, Cho IS, Sheen YY, Kim DK: IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy. Kidney Int 2006;70: 1234-1243. (Pubitemid 44435174)
30. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, Morishita R, Johnson RJ: Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003;14:1535-1548. (Pubitemid 36687055)